Ingevity Corp Files 8-K on Financials

Ticker: NGVT · Form: 8-K · Filed: 2025-05-05T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, 8-k

Related Tickers: NGVT

TL;DR

Ingevity Corp dropped an 8-K on May 5th - check their financials.

AI Summary

On May 5, 2025, Ingevity Corp. filed an 8-K report detailing results of operations and financial condition, along with financial statements and exhibits. The filing is a current report under the Securities Exchange Act of 1934.

Why It Matters

This 8-K filing provides an update on Ingevity Corp's financial performance and condition, which is crucial information for investors and stakeholders to assess the company's health and future prospects.

Risk Assessment

Risk Level: low — This filing is a standard current report and does not appear to contain any immediately alarming or significant new information.

Key Players & Entities

FAQ

What is the purpose of this 8-K filing?

This 8-K filing serves as a current report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934, detailing Ingevity Corp's results of operations and financial condition, and including financial statements and exhibits.

When was this report filed?

The report was filed on May 5, 2025.

What is Ingevity Corp's state of incorporation?

Ingevity Corp is incorporated in Delaware.

What is the principal executive office address for Ingevity Corp?

The principal executive office address is 4920 O'Hear Avenue, Suite 400, North Charleston, South Carolina 29405.

What is the SIC code for Ingevity Corp?

The Standard Industrial Classification (SIC) code for Ingevity Corp is 2800, which falls under CHEMICALS & ALLIED PRODUCTS.

From the Filing

0001653477-25-000062.txt : 20250505 0001653477-25-000062.hdr.sgml : 20250505 20250505161736 ACCESSION NUMBER: 0001653477-25-000062 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20250505 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250505 DATE AS OF CHANGE: 20250505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ingevity Corp CENTRAL INDEX KEY: 0001653477 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 474027764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37586 FILM NUMBER: 25913215 BUSINESS ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 BUSINESS PHONE: 8437402300 MAIL ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 8-K 1 ngvt-20250505.htm 8-K ngvt-20250505 false Ingevity Corp 0001653477 0001653477 2025-05-05 2025-05-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________  FORM 8-K _______________________________________________________________________ CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 May 5, 2025 Date of Report (date of earliest event reported) __________________________________________________________________________ INGEVITY CORPORATION (Exact name of registrant as specified in its charter) __________________________________________________________________________  Delaware 001-37586 47-4027764 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 4920 O'Hear Avenue Suite 400 North Charleston South Carolina 29405 (Address of principal executive offices) (Zip code) Registrant’s telephone number, including area code: 843 - 740-2300 Not Applicable (Former name or former address, if changed since last report) _____________________________________________________________________________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock ($0.01 par value) NGVT New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐ Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act o _____________________________________________________________________________________________________ ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION On May 5, 2025 , Ingevity Corporation ("Ingevity") announced its preliminary financial results for the three months ended March 31, 2025 which are attached as Exhibit 99.1 to this Current Report on Form 8-K. Please refer

View on Read The Filing